Thornberry Nancy
Insider · Vertex Pharmaceuticals Inc / MA (VRTX)
planned sales: $547,860
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 16, 2026 | Planned sale 10b5-1 plan | 1,000 | — | $547,860 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
